Hamdard, J.; Yücel, M.H.; Muğlu, H.; Açıkgöz, Ö.; Çakır, A.; Bilici, A.; Ölmez, Ö.F.
Clinical Outcomes in Early-Stage HER2-Low and HER2-Zero Breast Cancer: Single-Center Experience. J. Clin. Med. 2025, 14, 2937.
https://doi.org/10.3390/jcm14092937
AMA Style
Hamdard J, Yücel MH, Muğlu H, Açıkgöz Ö, Çakır A, Bilici A, Ölmez ÖF.
Clinical Outcomes in Early-Stage HER2-Low and HER2-Zero Breast Cancer: Single-Center Experience. Journal of Clinical Medicine. 2025; 14(9):2937.
https://doi.org/10.3390/jcm14092937
Chicago/Turabian Style
Hamdard, Jamshid, Mehmet Haluk Yücel, Harun Muğlu, Özgür Açıkgöz, Aslı Çakır, Ahmet Bilici, and Ömer Fatih Ölmez.
2025. "Clinical Outcomes in Early-Stage HER2-Low and HER2-Zero Breast Cancer: Single-Center Experience" Journal of Clinical Medicine 14, no. 9: 2937.
https://doi.org/10.3390/jcm14092937
APA Style
Hamdard, J., Yücel, M. H., Muğlu, H., Açıkgöz, Ö., Çakır, A., Bilici, A., & Ölmez, Ö. F.
(2025). Clinical Outcomes in Early-Stage HER2-Low and HER2-Zero Breast Cancer: Single-Center Experience. Journal of Clinical Medicine, 14(9), 2937.
https://doi.org/10.3390/jcm14092937
